vs
奎斯特诊断（DGX）与RENAISSANCERE HOLDINGS LTD（RNR）财务数据对比。点击上方公司名可切换其他公司
奎斯特诊断的季度营收约是RENAISSANCERE HOLDINGS LTD的1.3倍（$2.9B vs $2.2B），RENAISSANCERE HOLDINGS LTD净利率更高（23.5% vs 9.7%，领先13.8%），奎斯特诊断同比增速更快（9.2% vs -36.8%），过去两年奎斯特诊断的营收复合增速更高（9.9% vs -11.9%）
奎斯特诊断是美国头部临床检验服务商，位列《财富》500强，业务覆盖美国、波多黎各、墨西哥及巴西，同时与全球范围内多家医院、诊所保持长期协作关系，为不同地区的客户提供专业临床检验相关服务。
RenaissanceRe Holdings Ltd是总部位于百慕大的保险及相关商业服务提供商，核心业务覆盖再保险、常规保险两大板块，同时运营风险相关创新投资业务，为全球客户提供专业的风险对冲与保险解决方案。
DGX vs RNR — 直观对比
营收规模更大
DGX
是对方的1.3倍
$2.2B
营收增速更快
DGX
高出45.9%
-36.8%
净利率更高
RNR
高出13.8%
9.7%
两年增速更快
DGX
近两年复合增速
-11.9%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $2.9B | $2.2B |
| 净利润 | $281.0M | $515.8M |
| 毛利率 | — | — |
| 营业利润率 | 15.4% | — |
| 净利率 | 9.7% | 23.5% |
| 营收同比 | 9.2% | -36.8% |
| 净利润同比 | 12.0% | 72.6% |
| 每股收益（稀释后） | $2.24 | $6.57 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DGXRNR
| Q1 26 | $2.9B | $2.2B | ||
| Q4 25 | $2.8B | $3.0B | ||
| Q3 25 | $2.8B | $3.2B | ||
| Q2 25 | $2.8B | $3.2B | ||
| Q1 25 | $2.7B | $3.5B | ||
| Q4 24 | $2.6B | $2.3B | ||
| Q3 24 | $2.5B | $4.0B | ||
| Q2 24 | $2.4B | $2.8B |
净利润DGXRNR
| Q1 26 | $281.0M | $515.8M | ||
| Q4 25 | $245.0M | $760.5M | ||
| Q3 25 | $245.0M | $916.5M | ||
| Q2 25 | $282.0M | $835.4M | ||
| Q1 25 | $220.0M | $170.0M | ||
| Q4 24 | $222.0M | $-189.7M | ||
| Q3 24 | $226.0M | $1.2B | ||
| Q2 24 | $229.0M | $503.9M |
毛利率DGXRNR
| Q1 26 | — | — | ||
| Q4 25 | 32.4% | — | ||
| Q3 25 | 33.7% | — | ||
| Q2 25 | 34.2% | — | ||
| Q1 25 | 32.5% | — | ||
| Q4 24 | 32.7% | — | ||
| Q3 24 | 32.6% | — | ||
| Q2 24 | 33.5% | — |
营业利润率DGXRNR
| Q1 26 | 15.4% | — | ||
| Q4 25 | 13.8% | 42.5% | ||
| Q3 25 | 13.7% | 46.3% | ||
| Q2 25 | 15.9% | 41.8% | ||
| Q1 25 | 13.0% | -2.0% | ||
| Q4 24 | 13.8% | -3.6% | ||
| Q3 24 | 13.3% | 43.7% | ||
| Q2 24 | 14.8% | 25.0% |
净利率DGXRNR
| Q1 26 | 9.7% | 23.5% | ||
| Q4 25 | 8.7% | 25.6% | ||
| Q3 25 | 8.7% | 28.7% | ||
| Q2 25 | 10.2% | 26.1% | ||
| Q1 25 | 8.3% | 4.9% | ||
| Q4 24 | 8.5% | -8.3% | ||
| Q3 24 | 9.1% | 29.8% | ||
| Q2 24 | 9.6% | 17.8% |
每股收益（稀释后）DGXRNR
| Q1 26 | $2.24 | $6.57 | ||
| Q4 25 | $2.18 | $16.16 | ||
| Q3 25 | $2.16 | $19.40 | ||
| Q2 25 | $2.47 | $17.20 | ||
| Q1 25 | $1.94 | $3.27 | ||
| Q4 24 | $1.95 | $-3.76 | ||
| Q3 24 | $1.99 | $22.62 | ||
| Q2 24 | $2.03 | $9.41 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $393.0M | $1.6B |
| 总债务越低越好 | $5.7B | — |
| 股东权益账面价值 | $7.7B | $4.3B |
| 总资产 | $16.7B | $53.7B |
| 负债/权益比越低杠杆越低 | 0.74× | — |
8季度趋势，按日历期对齐
现金及短期投资DGXRNR
| Q1 26 | $393.0M | $1.6B | ||
| Q4 25 | $420.0M | $1.7B | ||
| Q3 25 | $432.0M | $1.7B | ||
| Q2 25 | $319.0M | $1.4B | ||
| Q1 25 | $188.0M | $1.6B | ||
| Q4 24 | $549.0M | $1.7B | ||
| Q3 24 | $764.0M | $1.6B | ||
| Q2 24 | $271.0M | $1.6B |
总债务DGXRNR
| Q1 26 | $5.7B | — | ||
| Q4 25 | $5.2B | $2.3B | ||
| Q3 25 | $5.2B | $2.2B | ||
| Q2 25 | $5.2B | $2.3B | ||
| Q1 25 | $5.9B | $2.8B | ||
| Q4 24 | $5.6B | $1.9B | ||
| Q3 24 | $5.6B | $1.9B | ||
| Q2 24 | $3.8B | $2.0B |
股东权益DGXRNR
| Q1 26 | $7.7B | $4.3B | ||
| Q4 25 | $7.2B | $11.6B | ||
| Q3 25 | $7.3B | $11.5B | ||
| Q2 25 | $7.2B | $10.8B | ||
| Q1 25 | $6.9B | $10.3B | ||
| Q4 24 | $6.8B | $10.6B | ||
| Q3 24 | $6.8B | $11.2B | ||
| Q2 24 | $6.6B | $10.2B |
总资产DGXRNR
| Q1 26 | $16.7B | $53.7B | ||
| Q4 25 | $16.2B | $53.8B | ||
| Q3 25 | $16.2B | $54.5B | ||
| Q2 25 | $16.0B | $54.7B | ||
| Q1 25 | $15.8B | $53.6B | ||
| Q4 24 | $16.2B | $50.7B | ||
| Q3 24 | $16.1B | $52.8B | ||
| Q2 24 | $13.9B | $51.6B |
负债/权益比DGXRNR
| Q1 26 | 0.74× | — | ||
| Q4 25 | 0.72× | 0.20× | ||
| Q3 25 | 0.71× | 0.19× | ||
| Q2 25 | 0.72× | 0.21× | ||
| Q1 25 | 0.85× | 0.27× | ||
| Q4 24 | 0.83× | 0.18× | ||
| Q3 24 | 0.83× | 0.17× | ||
| Q2 24 | 0.58× | 0.19× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $278.0M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 3.9% | — |
| 现金转化率经营现金流/净利润 | 0.99× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流DGXRNR
| Q1 26 | $278.0M | — | ||
| Q4 25 | $465.0M | $483.0M | ||
| Q3 25 | $563.0M | $1.6B | ||
| Q2 25 | $544.0M | $1.5B | ||
| Q1 25 | $314.0M | $157.8M | ||
| Q4 24 | $464.0M | $778.9M | ||
| Q3 24 | $356.0M | $1.5B | ||
| Q2 24 | $360.0M | $1.2B |
自由现金流DGXRNR
| Q1 26 | — | — | ||
| Q4 25 | $307.0M | — | ||
| Q3 25 | $419.0M | — | ||
| Q2 25 | $436.0M | — | ||
| Q1 25 | $197.0M | — | ||
| Q4 24 | $341.0M | — | ||
| Q3 24 | $250.0M | — | ||
| Q2 24 | $268.0M | — |
自由现金流率DGXRNR
| Q1 26 | — | — | ||
| Q4 25 | 10.9% | — | ||
| Q3 25 | 14.9% | — | ||
| Q2 25 | 15.8% | — | ||
| Q1 25 | 7.4% | — | ||
| Q4 24 | 13.0% | — | ||
| Q3 24 | 10.0% | — | ||
| Q2 24 | 11.2% | — |
资本支出强度DGXRNR
| Q1 26 | 3.9% | — | ||
| Q4 25 | 5.6% | — | ||
| Q3 25 | 5.1% | — | ||
| Q2 25 | 3.9% | — | ||
| Q1 25 | 4.4% | — | ||
| Q4 24 | 4.7% | — | ||
| Q3 24 | 4.3% | — | ||
| Q2 24 | 3.8% | — |
现金转化率DGXRNR
| Q1 26 | 0.99× | — | ||
| Q4 25 | 1.90× | 0.64× | ||
| Q3 25 | 2.30× | 1.73× | ||
| Q2 25 | 1.93× | 1.76× | ||
| Q1 25 | 1.43× | 0.93× | ||
| Q4 24 | 2.09× | — | ||
| Q3 24 | 1.58× | 1.26× | ||
| Q2 24 | 1.57× | 2.41× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
